Home
  • Home
  • Resources
  • Diseases
  • Training
  • SYSVAC
    • About
    • Registry
    • E-learning courses
  • News
  • Events
  • Webinars
  • Network
    • Steering Committee
    • Vision and Mission
    • Map
    • Meetings
    • Partners
    • Join us
  • Home
  • Resources

Resources

Selected

No filters selected.

Type of publications
  • Guidelines (30)
  • NITAG documentation (1569)
  • Reports (55)
  • SAGE documentation (199)
  • Scientific publications (111)
  • Systematic reviews (SYSVAC) (2561)
Topics
Regions
  • Africa (255)
  • Americas (749)
  • Eastern Mediterranean (42)
  • Europe (687)
  • South-East Asia (76)
  • Western Pacific (191)
Countries
Diseases
  • Chikungunya (1)
  • Cholera (30)
  • COVID-19 (1398)
  • Dengue (38)
  • Diphtheria (78)
  • Ebola (13)
  • Escherichia coli (ETEC) (2)
  • Haemophilus influenzae type B (66)
  • Hepatitis A (62)
  • Hepatitis B (148)
  • Hepatitis C (4)
  • Hepatitis E (1)
  • Herpes simplex (1)
  • Herpes zoster (61)
  • HIV / AIDS (10)
  • Human papillomavirus (HPV) (447)
  • Influenza (554)
  • Japanese encephalitis (34)
  • Lyme disease, Borreliosis (1)
  • Malaria (24)
  • Measles (120)
  • Meningococcal disease (143)
  • Mpox (41)
  • Mumps (45)
  • Pertussis (100)
  • Pneumococcal disease (259)
  • Poliomyelitis (69)
  • Q fever (1)
  • Rabies (27)
  • Rotavirus (113)
  • RSV (Respiratory syncytial virus) (36)
  • Rubella (61)
  • Salmonella (2)
  • Shigella (1)
  • Smallpox (15)
  • Streptococcus group B (6)
  • Tetanus (56)
  • Tick-borne encephalitis (11)
  • Tuberculosis (70)
  • Typhoid (22)
  • Varicella (68)
  • Yellow fever (40)
  • Zika (1)
Vaccine topics
Target population
Methodological quality (AMSTAR 2)
Publication date
Available to download in languages
2025 ∙ NACI
NACI Statement on seasonal influenza vaccines for 2025–2026
  • Recommendation
  • Canada
  • Influenza
Download:
  • EN
2025 ∙ Health Council of the Netherlands
COVID-19 vaccination in 2025 in the Netherlands
  • Recommendation
  • Netherlands
  • COVID-19
2025 ∙ Health Council of the Netherlands
RSV vaccination for the elderly
  • Recommendation
  • Netherlands
  • RSV (Respiratory syncytial virus)
2025 ∙ ATAGI
ATAGI statement on the administration of COVID-19 vaccines in 2025
  • Recommendation
  • Australia
  • COVID-19
Download:
  • EN
2025 ∙ ATAGI
ATAGI statement on the administration of seasonal influenza vaccines in 2025
  • Recommendation
  • Australia
  • Influenza
Download:
  • EN
2025 ∙ Folkhälsomyndigheten
Vaccination against mpox – a second update of vaccine recommendations due to increased spread of mpox clade 1
  • Recommendation
  • Sweden
  • Mpox
Download:
  • EN
2025 ∙ Conseil Supérieur de la Santé (CSS)
Vaccination against Yellow Fever in Belgium
  • Recommendation
  • Belgium
  • Yellow fever
Download:
  • EN
2025 ∙ NACI
Rapid response: Preliminary guidance on human vaccination against avian influenza in a non-pandemic context as of December 2024
  • Recommendation
  • Canada
Download:
  • EN
2025 ∙ CAVEI
CAVEI recommendation on annual vaccination against COVID-19 for the year 2025
  • Recommendation
  • Chile
  • COVID-19
2025 ∙ NACI
Guidance on the use of COVID-19 vaccines for 2025 to summer 2026
  • Recommendation
  • Canada
  • COVID-19
Download:
  • EN
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • ...
  • Home
  • Resources
  • Diseases
  • Training
  • SYSVAC
  • News
  • Events
  • Webinars
  • Network
  • Sign in / Register
National Immunization Technical Advisory Groups
  • Home
  • Resources
  • Diseases
  • Training
  • SYSVAC
  • News
  • Events
  • Webinars
  • Network
© 2025

Footer legal info

  • Legal Notice
Subscription to the monthly updates

On the last Wednesday of every month, we send updates about the latest NITAG recommendations in each region, relevant articles related to NITAG work, and other big announcements. Don’t miss them out!

Loading...